期刊文献+

E钙黏蛋白和VEGF的表达与乳腺癌发生的关系 被引量:2

The Relationship between Expression of E-Cad,VEGF and Breast Cancer
下载PDF
导出
摘要 目的探讨E钙黏蛋白(E-Cad)和血管内皮生长因子(VEGF)的表达与乳腺浸润性导管癌(IDC)和乳腺导管内癌(DCIS)发生的关系,为判定乳腺癌的预后提供一定的理论依据。方法应用免疫组织化学染色法检测82例IDC(Ⅰ~Ⅱ期22例、Ⅲ期60例)及33例DCIS组织中E-Cad及VEGF的表达水平。结果 E-Cad在IDC组中强阳性表达率低于DCIS组(P<0.05);在Ⅲ期乳腺癌组中强阳性率低于Ⅰ~Ⅱ期(P<0.05);在有淋巴结转移的乳腺癌组强阳性表达率低于无淋巴结转移的乳腺癌组(P<0.05)。VEGF在IDC组中强阳性表达率高于DCIS组(P<0.05);在Ⅲ期乳腺癌组中强阳性率高于Ⅰ~Ⅱ期(P<0.05);在有淋巴结转移的乳腺癌组强阳性表达率高于无淋巴结转移的乳腺癌组(P<0.05)。结论 E-Cad在IDC组织中的表达低于DCIS组织,VEGF在IDC组织中的表达高于DCIS组织,两者表达呈明显负相关,且两者表达均与淋巴结转移、乳腺癌组织分级有关。 Objective To explore the relationship between expressions of epithelial-cadherin(E-Cad)and vascular endothelial growth factor(VEGF)with breast invasive ductal carcinoma(IDC)and breast ductal carcinoma in situ(DICS),and to provide certain theoretical basis for the prognosis of breast cancer.Methods Expressions of both E-Cad and VEGF were determined in 82 cases of IDC(stageⅠ-Ⅱ,22 cases;stage Ⅲ,60 cases)and 33 cases of DCI by immunohistochemistry.Results Strongly positive expression of E-Cad in IDC group was lower than that in DCIS group(P0.05),at stage Ⅲ was lower than that at stage Ⅰ-Ⅱ(P0.05),in patients with lymph node metastasis was lower than that in patients without lymph node metastasis(P0.05).While strongly positive expression of VEGF in IDC group was higher than that in DCIS group(P0.05),at stage Ⅲ was higher than that at stage Ⅰ-Ⅱ(P0.05),in patients with lymph node metastasis was higher than in patients without lymph node metastasis(P0.05).Conclusion The expression of E-Cad in IDC tissues was lower than that in DCIS tissues,The expression of VEGF in IDC tissues was higher than that in DCIS tissues.There was a negative correlation,the expression of either was correlated to the lymph node metastasis and the histological grade.
作者 曹志红 陈颖
出处 《医学综述》 2013年第3期538-540,共3页 Medical Recapitulate
关键词 E钙黏蛋白 血管内皮生长因子 乳腺癌 免疫组织化学 E-cadherin Vascular endothelial growth factor Breast cancer Immunohistochemistry
  • 相关文献

参考文献11

  • 1Jiang WG,Mansel RE. E-cadherin complex and its abnormalities in human breast cancer[J].Surg Oncot,2000,(04):151-171.
  • 2Llyas M. Adhesion molecule expression in breast cancer-the phoenix intumor metastasis[J].Journal of Pathology,2000,(01):3-5.doi:10.1002/(SICI)1096-9896(200001)190:1&lt;3::AID-PATH490&gt;3.0.CO;2-5.
  • 3Asqeirsson KS,Jonasson JG,Tryqqvadottir L. Altered expression of e-cadherin in breast cancer:patterns,mechanisms and clinical sgnificance[J].European Journal of Cancer,2000,(09):1098-1106.
  • 4Onder TT,Gupta PB,Mani SA. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways[J].Cancer Research,2008,(10):3645-3654.doi:10.1158/0008-5472.CAN-07-2938.
  • 5Gillett CE,Miles DW,Ryder K. Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade Ⅲ ductal carcinoma of the breast[J].Journal of Pathology,2001,(04):433-441.doi:10.1002/path.831.
  • 6Kleer CG,Van Golen KL,Braun T. Persistent e-cadherin expression in inflammatory breast cancer[J].Modern Pathology,2001,(05):458-463.
  • 7Heimann R,Lan F,McBride R. Separating favorable from unfavorable prognostic markers in breast cancer:the role of e-cadherin[J].Cancer Research,2000,(02):298-304.
  • 8Kaio E,Tanaka S,Kitadai Y. Clinical significance of angiogenic factor expression at the deepest invasive site of advanced carcinoma[J].Oncology(Basel),2003,(01):61-73.
  • 9Foekens JA,Peters HA,Grebenchtchikov N. High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer[J].Cancer Research,2001,(14):5407-5414.
  • 10Krippl P,Lanqsenlehner U,Renner W. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk[J].International Journal of Cancer,2003,(04):468-471.

同被引文献18

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部